1Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms reractory to proton pump inhibitors [J]. Gut,2012,61(9) : 1340-1354. DOI: 10. l136/gutjnl-2011- 301897.
2Xiao Y, Liang M, Peng S, et al. Tailored therapy for the refractory GERD patients by combined multichannelintraluminal impedance-pH monitoring[J]. J Gastroenterol Hepatol, 2016,31(2) :350-354. DOI10. llll/]gh. 13049.
3Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy a multicentre study using combined ambulatory impedanee-pH monitoring[J]. Gut, 2006,55 (10) : 1398-1402.
4Gunaratnam NT, Jessup TP, Inadomi J, et ah Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease [ J ]. Aliment Pharmacol Ther, 2006,23 (10) : 1473-1477. DOI 10. 1111/j. 1365-2036. 2006. 02911. x.
5Raekoff A, Agrawal A, Hila A, et al. Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy[J]. Dis Esophagus, 2005,18(6)370-373. DOI: 10. 1111/j. 1442- 2050. 2005. 00518. x.
6Hershcovici T, Fass R. An algorithm for diagnosis and treatment of refractory GERD [J]. Best Pratt Res Clin GastroenteroI, 2010, 24 (6) 923-936. DOI: 10. 1016/j. bpg. 2010. 10. 004.
7Zerbib F, Roman S, Ropert A, et al. Esophageal pH- impedance monitoring and symptom analysis in GERD a study in patients off and on therapy[J]. Am J Gastroenterol,2006, 101(9) .. 1956-1963.
8Noar M, Squires P, Noar E, et al. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later[J]. Surg Endosc,2014, 28(8) 2323-2333. DOI 10. 1007/s00464-014-3461-6.
